AI-Controlled Synthetic Thyroid Valve for Hormone Homeostasis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods for treating hypothyroidism, such as daily oral levothyroxine, face challenges due to fluctuations in ingestion times, dietary conditions, patient needs, and brand variations, leading to metabolic imbalances and inadequate treatment.
Innovation Solution
An AI-driven system that uses blood sensors to measure thyroid hormone levels and a valve delivery mechanism to automatically adjust and maintain optimal hormone concentrations in the bloodstream, employing deep learning algorithms and reinforcement learning to optimize thyroid hormone delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If conventional oral levothyroxine is used for thyroid hormone replacement, then treatment is simple and easy to administer, but metabolic imbalances occur due to fluctuations in ingestion times, dietary conditions, and patient needs
Solution Approach 1:
The patent implements a closed-loop feedback system where blood sensors continuously monitor thyroid hormone levels (T3, T4) and metabolic parameters, feeding this data to an AI processor that adjusts valve opening duration and frequency to maintain optimal hormone concentrations, thereby resolving the contradiction between ease of administration and metabolic homeostasis
Solution Approach 2:
The synthetic thyroid system performs self-adjustment through autonomous AI processing of sensor data and automatic valve control, eliminating the need for manual dosage adjustments by patients while maintaining reliable metabolic homeostasis
2Device complexity
If manual medication management is used, then device complexity is low, but treatment reliability deteriorates due to patient compliance issues and inability to respond to changing patient needs
Solution Approach 1:
The patent replaces manual mechanical medication administration with an automated electromechanical system featuring blood sensors, AI processor, and controlled valve mechanism, achieving consistent reliable treatment through electronic control while managing complexity through integrated design
3Ease of manufacture
If fixed dosage thyroid hormone replacement is used, then manufacturing and dosing are simple, but adaptability to individual patient variations and changing conditions is poor
Solution Approach 1:
The patent transforms fixed static dosage into dynamic adjustable dosing through AI-controlled valve operation that continuously adapts opening duration and frequency based on real-time blood hormone level measurements and patient-specific metabolic characteristics, achieving both manufacturability and adaptability
4Reliability
If blood hormone level monitoring and automatic valve delivery is implemented, then metabolic homeostasis is maintained, but device complexity and manufacturing difficulty increase
Solution Approach 1:
The patent integrates multiple functions into unified components: the processor serves as both AI decision-making unit and control signal generator, the valve mechanism handles both hormone delivery and flow regulation, and the blood sensors provide both diagnostic data and feedback for control, reducing overall system complexity through functional integration
Data Source
AI summary
A method and apparatus for thyroid hormone control using a synthetic module containing thyroid hormone and an intelligent valve control device. In embodiments, the invention consists of an iterative process with three steps. First, blood is measured to detect thyroid hormone concentration. Second, the measured concentration is compared to a target thyroid hormone concentration. Third, the intelligent valve control device optimizes thyroid hormone delivery, correcting for differences between the measured concentration and the target concentration.